Our results showed that the treatment of the cells with new case AML-EVs and relapsed AML-EVs increased the mRNA expression level of MRD1 and MRP1 as compared to the cells, which were treated with healthy EVs (Figure 6). The gene discussed is ABCC1; the disease is acute myeloid leukemia.